...
首页> 外文期刊>Pakistan journal of medical sciences. >Effects of siRNA-mediated HIF-1α gene silencing on angiogenesis in osteosarcoma
【24h】

Effects of siRNA-mediated HIF-1α gene silencing on angiogenesis in osteosarcoma

机译:siRNA介导的HIF-1α基因沉默对骨肉瘤血管生成的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: To explore angiogenesis in osteosarcoma under the condition of hypoxia-inducible factor (HIF)-1α gene silenced by small interference RNA (siRNA).Methods: The SaOS-2 osteosarcoma cells, transfected with the recombinant plasmid pSilencer2.1-HIF-1α or pSilencer2.1-SCR, were classified as HIF-1α/siRNA group or SCR/siRNA group, respectively. In which, vascular endothelial growth factor (VEGF) immunohistochemistry were performed. HIF-1α and VEGF protein contents were detected by western blot. Gene expressions of HIF-1α and VEGF were quantified by qPCR. Then the transfected SaOS-2 cells were inoculated in nude mice and transplantation tumor were checked via HE staining, VEGF and CD34 immunohistochemistry, and calculation of microvascular density (MVD).Results: In vitro, VEGF immunohistochemistry stains, HIF-1α and VEGF protein contents, and the relative expressions of HIF-1α mRNA and VEGF mRNA in HIF-1α/siRNA group were obviously reduced. In vivo, morphological observation illustrated that heteromorphism were not obvious in the cells of HIF-1α/siRNA group and vascular systems were sparse in its transplantation tumor tissue, and immunohistochemistry revealed that both VEGF and CD34 stains were significantly decreased in HIF-1α/siRNA group, and MVD in HIF-1α/siRNA group (7.3±1.1) were obviously less than that in SCR/siRNA group (17.2±3.2) (P<0.05).Conclusion: Angiogenesis in osteosarcoma can be inhibited by siRNA-mediated HIF-1α gene silencing, which is expected to provide a novel and attractive target of therapeutic strategies of osteosarcoma.
机译:目的:探讨低干扰RNA(siRNA)沉默低氧诱导因子(HIF)-1α基因在骨肉瘤中的血管生成。方法:用重组质粒pSilencer2.1-HIF-转染SaOS-2骨肉瘤细胞。将1α或pSilencer2.1-SCR分别分类为HIF-1α/ siRNA组或SCR / siRNA组。其中,进行了血管内皮生长因子(VEGF)的免疫组化。 Western blot检测HIF-1α和VEGF蛋白含量。通过qPCR定量HIF-1α和VEGF的基因表达。然后将转染的SaOS-2细胞接种到裸鼠体内,通过HE染色,VEGF和CD34免疫组化检查移植瘤,并计算微血管密度(MVD)。结果:体外,VEGF免疫组化染色,HIF-1α和VEGF蛋白HIF-1α/ siRNA组中HIF-1α和VEGF mRNA的相对含量明显降低。在体内,形态学观察表明,HIF-1α/ siRNA组细胞移植瘤组织中异质性不明显,血管系统稀疏,免疫组化显示HIF-1α/ siRNA中VEGF和CD34染色均明显降低。 HIF-1α/ siRNA组的MVD(7.3±1.1)明显低于SCR / siRNA组的MVD(17.2±3.2)(P <0.05)。结论:siRNA介导的HIF可抑制骨肉瘤血管生成-1α基因沉默有望为骨肉瘤的治疗策略提供一种新颖而有吸引力的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号